Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

Macrophage activation syndrome can be a deadly first sign of systemic lupus erythematosus.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

Clinical signs don't match inflammation levels in lichen planopilaris and frontal fibrosing alopecia.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Tretinoin gel is safe for sun exposure, but tacalcitol doesn't significantly improve non-segmental vitiligo.

Targeting regulatory T cells may help treat age-related diseases.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Repeated biopsies are crucial for managing lupus panniculitis when initial treatments fail.

Foxp3+ Regulatory T Cells are important for immunity and tolerance, affect hair growth and wound healing, and their dysfunction can contribute to obesity-related diseases and other health issues.

Targeting Vδ1+T-cells may help treat alopecia areata.

T cells affect skin cell genes in inflammatory diseases, and therapy can normalize these changes.

BTNL proteins help control inflammatory bowel disease by maintaining specific immune cells.

Intestinal intraepithelial lymphocytes are crucial for gut immunity and maintaining the mucosal barrier.

Farudodstat may help prevent hair loss in alopecia areata by stopping immune attacks on hair follicles.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Psoriasis involves an imbalance between certain immune cells, and targeting these could help restore skin health.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

Regulatory T cells help prevent autoimmunity and have potential for treating autoimmune diseases.

Fucoidan reduces bone cell formation by affecting T-cell activity.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Farudodstat can prevent hair follicle immune damage linked to alopecia areata.

CD44 variant changes start alopecia areata, but don't maintain it.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

γδ T cells are essential for wound healing after poxvirus infection.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.